Showing results (391-400 of 412) with videos related to

Sort By:
Pageof 42
The American Journal of Clinical Nutrition|September 28, 2019
Changing from a Western to a Mediterranean-style diet does not affect iron or selenium status: results of the New Dietary Strategies Addressing the Specific Needs of the Elderly Population for Healthy Aging in Europe (NU-AGE) 1-year randomized clinical trial in elderly EuropeansAmy Jennings, Jonathan Tang, Rachel Gillings, et al.
Acta Dermato-Venereologica|November 8, 2017
Search for RASA1 Variants in Capillary Malformations of the Legs in 113 Children: Results from the French National Paediatric Cohort CONAPEAnnabel Maruani, Marine Durieux-Verde, Juliette Mazereeuw-Hautier, et al.
Bioorganic & Medicinal Chemistry Letters|November 25, 2010
Synthesis and optimization of novel 4,4-disubstituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitorsDaqing Sun, Zhulun Wang, Seb Caille, et al.
JAMA|September 3, 2020
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical TrialPierre-François Dequin, Nicholas Heming, Ferhat Meziani, et al.
Trials|February 26, 2025
Guidelines for the content of statistical analysis plans in clinical trials: protocol for an extension to cluster randomized trialsKarla Hemming, Jacqueline Y Thompson, Richard L Hooper, et al.
ACS Central Science|April 28, 2025
Scaling Organic Electrosynthesis: The Crucial Interplay between Mechanism and Mass TransportZachary J Oliver, Dylan J Abrams, Luana Cardinale, et al.
Journal of Medicinal Chemistry|June 17, 2008
Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo modelLisa D Julian, Zhulun Wang, Tracy Bostick, et al.
ACS Chemical Biology|July 20, 2016
Facile Modulation of Antibody Fucosylation with Small Molecule Fucostatin Inhibitors and Cocrystal Structure with GDP-Mannose 4,6-DehydrataseJohn G Allen, Mirna Mujacic, Michael J Frohn, et al.
Trials|December 19, 2019
Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trialSophie Leducq, Agnès Caille, Sébastien Barbarot, et al.
BMJ Open|July 28, 2022
Impact of a phone call with a medical student/general practitioner team on morbidity of chronic patients during the first French COVID-19 lockdown (COVIQuest): a cluster randomised trialClarisse Dibao-Dina, Julie Léger, Isabelle Ettori-Ajasse, et al.
Pageof 42